-+ 0.00%
-+ 0.00%
-+ 0.00%

Novo Nordisk Reports DKK 6.3B Non-Recurring, Non-Cash Impairment Charges In Q2 Related To Intangible Pipeline Assets

Benzinga·08/04/2026 16:46:22
Listen to the news

https://www.novonordisk.com/news-and-media/news-and-ir-materials/news-details.html?id=916590